Cargando…
SAT-340 27-Hydroxycholesterol Acts on Myeloid Cells to Inhibit T Cell Expansion
Breast cancer is the most commonly diagnosed cancer and among the leading causes of death among women in the United States. Our previous work has found that a metabolite of cholesterol, 27-hydroxycholesterol (27HC) promotes breast cancer metastasis in preclinical models. 27HC is a ligand of both the...
Autores principales: | Ma, Liqian, Baek, Amy, Nelson, Erik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552196/ http://dx.doi.org/10.1210/js.2019-SAT-340 |
Ejemplares similares
-
THU482 The Cholesterol Metabolite, 27-hydroxycholesterol, Enhances The Secretion Of Cancer Promoting Extracellular Vesicles By Impairing Lysosomal Integrity
por: Gupta, Anasuya Das, et al.
Publicado: (2023) -
OR05-01 Small Heterodimer Partner Modulates Antigen Presenting Myeloid Cells to Impair Regulatory T Cell Expansion, Promoting Anti-Tumor Immunity in Models of Breast Cancer
por: Shahoei, Sayyed Hamed, et al.
Publicado: (2020) -
OR05-01 Myeloid Cell Intrinsic NR0B2 Inhibits Regulatory T Cell Expansion Within The Tumor Microenvironment: Potential Novel Strategy For Breast Cancer Immunotherapy
por: Vidana Gamage, Hashni Epa, et al.
Publicado: (2023) -
MON-340 Concomitant TIO and SIADH in a Patient with Neuroendocrine Tumor
por: Rahhal, Marie-Noel, et al.
Publicado: (2019) -
SUN-340 Prolactinoma Response to Bevacizumab Is Influenced by Tumor Progression Stage at the Beginning of Treatment
por: Valla, Sofia, et al.
Publicado: (2019)